Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00643617
What this trial is testing

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

Who this might be right for
Prostate CancerProstatic CancerProstatic Neoplasms+2 more
Accuray Incorporated 307
Testing effectiveness (Phase 2)UnknownNCT04523896
What this trial is testing

HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostatic Neoplasm
David Büchser 50
Testing effectiveness (Phase 2)UnknownNCT04985721
What this trial is testing

A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects

Who this might be right for
Cancer
Peter MacCallum Cancer Centre, Australia 60
Not applicableLooking for participantsNCT04231006
What this trial is testing

Salvage HDR for Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Aarhus University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02091050
What this trial is testing

2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy

Who this might be right for
Cervix CancerEndometrial Cancer
AC Camargo Cancer Center 60
Early research (Phase 1)UnknownNCT04764084
What this trial is testing

Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors

Who this might be right for
HER2-negative Breast CancerGastric AdenocarcinomaCholangiocarcinoma+1 more
Peking University Cancer Hospital & Institute 52
Large-scale testing (Phase 3)WithdrawnNCT02392676
What this trial is testing

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

Who this might be right for
Platinum Sensitive Relapsed Ovarian Cancer
AstraZeneca
Not applicableUnknownNCT05265117
What this trial is testing

The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study

Who this might be right for
Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 310
Not applicableLooking for participantsNCT04861415
What this trial is testing

SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer

Who this might be right for
Prostate Cancer
Dr. Gerard Morton 55
Testing effectiveness (Phase 2)Study completedNCT00924027
What this trial is testing

Patients Receiving High-Dose Rate Brachytherapy

Who this might be right for
Cervical CancerEndometrial CancerEsophageal Cancer+2 more
National Cancer Institute (NCI) 43
Not applicableUnknownNCT04870567
What this trial is testing

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Who this might be right for
Biochemical Relapse Free SurvivalComplications Rates (Erectile Dysfunction, GI, GU Complications)
N.N. Petrov National Medical Research Center of Oncology 350
Large-scale testing (Phase 3)Looking for participantsNCT07426055
What this trial is testing

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate BrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Not applicableStudy completedNCT04425200
What this trial is testing

Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

Who this might be right for
Prostatic Neoplasms
AstraZeneca 205
Not applicableUnknownNCT06518018
What this trial is testing

Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Stage NSCLCSecond-line TreatmentPatients Without Targetable Driver Mutations
The First People's Hospital of Neijiang 80
Not applicableStudy completedNCT03162523
What this trial is testing

Experiences With HDR-brachytherapy in Norway

Who this might be right for
Prostate Cancer
Oslo University Hospital 325
Large-scale testing (Phase 3)UnknownNCT03876886
What this trial is testing

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 200
Not applicableLooking for participantsNCT05754580
What this trial is testing

High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

Who this might be right for
Prostatic Cancer
University of Nebraska 53
Large-scale testing (Phase 3)Active Not RecruitingNCT02692105
What this trial is testing

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 60
Not applicableStudy completedNCT04716374
What this trial is testing

Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Hellenic Cooperative Oncology Group 550
Testing effectiveness (Phase 2)UnknownNCT01045148
What this trial is testing

CyberKnife Radiosurgery for Localized Prostatic Carcinoma

Who this might be right for
Prostate Cancer
CyberKnife Centers of San Diego 258
Next Page